Trials Open to Enrollment

Clinical trials are run at the Vancouver Prostate Centre and at our partner institution, the BC Cancer Agency. To learn more about prostate cancer trials and other GU cancer trials visit the BC Cancer Agency website. In addition, VCHRI has a searchable database of clinical trials at VCH.

A list of clinical trials that are currently recruiting patients at the Vancouver Prostate Centre are outlined below.  You can click on the links for detailed information where you’ll be taken to a registry federally and privately supported clinical trials conducted in Canada, the United States, and around the world. These websites give you information about a trial's purpose, who may participate, locations, and phone numbers for more details.

Note, this information should be used in conjunction with advice from health care professionals. Patients must be referred by their physician to be able to participate in a clinical trial.

Prostate Cancer

A Phase 3 Randomized, Placebo-controlled Double-blind Study of JNJ-56021927 in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)  - click here for more info

A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy - click here for more info

A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer – NCIC CTG PRC.3/CALGB 90203 - click here for more info

Canary Prostate Active Surveillance Study (PASS) - click here for more info

A phase IV, randomized, multicentre efficacy and safety study comparing 10 months versus 4 months of degarelix (Firmagon®) therapy in prolonging the off treatment interval in men with non-metastatic prostate cancer receiving intermittent androgen deprivation therapy for biochemical progression - click here for more info

A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer (MDV3100-14) - click here for more info

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer - click here for more info

A Randomized Phase II Study of Sequencing Abiraterone Acetate and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer - click here for more info

Bladder Cancer

A Phase III Surgical Trial to Evaluate the Benefit of a Standard versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer - click here for more info

Kidney Cancer

Canadian Kidney Cancer Information System (CKCis) - a database project - click here for more info

Randomized Phase III trial comparing immediate versus deferred nephrectomy in patients with synchronous metastatic renal cell carcinoma - click here for more info

Testicular Cancer

The role of MRI in the Management of Retroperitoneal Lymph Node Metastasis in Patients with Testicular Cancer

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Father's Day Walk/Run for Prostate Cancer: June 18

The Raymond James Father's Day Wak Run for Prostate Cancer, raising funds for Prostate Cancer Foundation BC, took place Sunday June 18.  The website is still open for donations; click here to donate.

 

Employment

Work at the Vancouver Prostate Centre

Monday, January 30, 2017

Dr. Amina Zoubeidi leads identification of gene linked to growth of aggressive neuroendocrine prostate cancer (NEPC)

DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.